Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center

BackgroundMargin positivity after gastric cancer resection is associated with poorer outcomes. However, the prognostic factors and the choice of postoperative adjuvant treatment of patients with positive margin (PM) after gastrectomy are still being debated.MethodsA single-center, retrospective anal...

Full description

Bibliographic Details
Main Authors: Xiaojie Zhang, Lulu Zhao, Penghui Niu, Tongbo Wang, Wanqing Wang, Chongyuan Sun, Zefeng Li, Yingtai Chen, Dongbing Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.794032/full
_version_ 1819294544244506624
author Xiaojie Zhang
Lulu Zhao
Penghui Niu
Tongbo Wang
Wanqing Wang
Chongyuan Sun
Zefeng Li
Yingtai Chen
Dongbing Zhao
author_facet Xiaojie Zhang
Lulu Zhao
Penghui Niu
Tongbo Wang
Wanqing Wang
Chongyuan Sun
Zefeng Li
Yingtai Chen
Dongbing Zhao
author_sort Xiaojie Zhang
collection DOAJ
description BackgroundMargin positivity after gastric cancer resection is associated with poorer outcomes. However, the prognostic factors and the choice of postoperative adjuvant treatment of patients with positive margin (PM) after gastrectomy are still being debated.MethodsA single-center, retrospective analysis was conducted for patients with PM after gastrectomy from the China National Cancer Center Gastric Cancer Database (NCCGCDB) from 1998 to 2018. Univariate and multivariate Cox regression analyses were performed to identify prognostic factors of overall survival (OS) and recurrence-free survival (RFS).ResultsA total of 449 patients were included in the study, including 192 (42.8%) in the proximal PM group (PPM), 205 (45.7%) in the distal PM group (DPM), and 52 (11.6%) in the bilateral PM group (BPM). The 3- and 5-year OS rates for the PM patients investigated were 47.5% and 39.3%, respectively, and the 3- and 5-year RFS rates were 60.0% and 53.6%, respectively. Multivariate Cox regression analysis proved total gastrectomy (hazard ratio (HR): 1.783, 95%CI: 1.133–2.805, p = 0.012), pT4 (HR: 5.264, 95%CI: 1.493–18.565, p = 0.01), pN2 (HR: 2.263, 95%CI: 1.164–4.397, p = 0.016), pN3 (HR: 2.327, 95%CI: 1.233–4.393, p = 0.009), and combined resection (HR: 1.952, 95%CI: 1.256–3.034, p = 0.003) to be independent risk factors of OS, and pT3 (HR: 9.257, 95%CI: 1.152–74.386, p = 0.036) and pT4 (HR: 11.361, 95%CI: 1.469–87.847, p = 0.020) to be independent risk factors for RFS. Adjuvant chemotherapy prolonged OS in the PPM group (p = 0.032) and prolonged RFS in the PPM group (p < 0.001) and the DPM group (p = 0.035) compared with surgery alone.ConclusionsAdvanced pathologic stage was associated with poor prognosis, and postoperative adjuvant chemotherapy might be recommended in PM patients after gastrectomy. Still, further prospective trials are warranted to verify and support our conclusions.
first_indexed 2024-12-24T04:28:00Z
format Article
id doaj.art-901ca674b9744f388f4d2e7ca0a9e0dc
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-24T04:28:00Z
publishDate 2022-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-901ca674b9744f388f4d2e7ca0a9e0dc2022-12-21T17:15:31ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-02-011110.3389/fonc.2021.794032794032Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single CenterXiaojie ZhangLulu ZhaoPenghui NiuTongbo WangWanqing WangChongyuan SunZefeng LiYingtai ChenDongbing ZhaoBackgroundMargin positivity after gastric cancer resection is associated with poorer outcomes. However, the prognostic factors and the choice of postoperative adjuvant treatment of patients with positive margin (PM) after gastrectomy are still being debated.MethodsA single-center, retrospective analysis was conducted for patients with PM after gastrectomy from the China National Cancer Center Gastric Cancer Database (NCCGCDB) from 1998 to 2018. Univariate and multivariate Cox regression analyses were performed to identify prognostic factors of overall survival (OS) and recurrence-free survival (RFS).ResultsA total of 449 patients were included in the study, including 192 (42.8%) in the proximal PM group (PPM), 205 (45.7%) in the distal PM group (DPM), and 52 (11.6%) in the bilateral PM group (BPM). The 3- and 5-year OS rates for the PM patients investigated were 47.5% and 39.3%, respectively, and the 3- and 5-year RFS rates were 60.0% and 53.6%, respectively. Multivariate Cox regression analysis proved total gastrectomy (hazard ratio (HR): 1.783, 95%CI: 1.133–2.805, p = 0.012), pT4 (HR: 5.264, 95%CI: 1.493–18.565, p = 0.01), pN2 (HR: 2.263, 95%CI: 1.164–4.397, p = 0.016), pN3 (HR: 2.327, 95%CI: 1.233–4.393, p = 0.009), and combined resection (HR: 1.952, 95%CI: 1.256–3.034, p = 0.003) to be independent risk factors of OS, and pT3 (HR: 9.257, 95%CI: 1.152–74.386, p = 0.036) and pT4 (HR: 11.361, 95%CI: 1.469–87.847, p = 0.020) to be independent risk factors for RFS. Adjuvant chemotherapy prolonged OS in the PPM group (p = 0.032) and prolonged RFS in the PPM group (p < 0.001) and the DPM group (p = 0.035) compared with surgery alone.ConclusionsAdvanced pathologic stage was associated with poor prognosis, and postoperative adjuvant chemotherapy might be recommended in PM patients after gastrectomy. Still, further prospective trials are warranted to verify and support our conclusions.https://www.frontiersin.org/articles/10.3389/fonc.2021.794032/fullgastric cancerpositive marginprognosisadjuvant chemotherapygastrectomy
spellingShingle Xiaojie Zhang
Lulu Zhao
Penghui Niu
Tongbo Wang
Wanqing Wang
Chongyuan Sun
Zefeng Li
Yingtai Chen
Dongbing Zhao
Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center
Frontiers in Oncology
gastric cancer
positive margin
prognosis
adjuvant chemotherapy
gastrectomy
title Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center
title_full Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center
title_fullStr Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center
title_full_unstemmed Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center
title_short Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center
title_sort adjuvant chemotherapy might be recommended to patients with positive margin after gastrectomy a 20 year retrospective analysis in a single center
topic gastric cancer
positive margin
prognosis
adjuvant chemotherapy
gastrectomy
url https://www.frontiersin.org/articles/10.3389/fonc.2021.794032/full
work_keys_str_mv AT xiaojiezhang adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter
AT luluzhao adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter
AT penghuiniu adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter
AT tongbowang adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter
AT wanqingwang adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter
AT chongyuansun adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter
AT zefengli adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter
AT yingtaichen adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter
AT dongbingzhao adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter